









Markets
/
Stocks
/
nasdaq-tdacu
/

Translational Development Acquisition Corp

TDACU

10.410USD

-0.020-0.19%

Market hours （ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM



Translational Development Acquisition Corp

10.410

-0.020-0.19%

Overview Company Financials

Income Statement

Cash Flow Statement

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024Q3

FY2023Q4

FY2023Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---40.48K

--0.00

--0.00

Net income from continuing operations

-12156.60%-61.28K

---483.85K

---500.00

Other non-cash items

----

--482.34K

----

Change in working capital

4060.00%20.80K

--1.51K

--500.00

-Change in prepaid expenses

-100.00%0.00

--500.00

--500.00

Cash from non-recurring investing activities

Cash from operating activities

---40.48K

--0.00

--0.00

Investing cash flow

Cash from non-current investing activities

Financing cash flow

Cash flow from continuous financing activities

--192.50K

--0.00

--0.00

Net cash flow from debt Issuance/repayment

--200.00K

--0.00

--0.00

Net cash flow from other financing activities

---7.50K

--0.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--192.50K

--0.00

--0.00

Net cash flow

Beginning cash balance

3463.63%72.02K

--2.02K

--2.02K

Current period cash flow changes

--152.02K

--0.00

--0.00

Ending cash balance

10985.50%224.04K

--2.02K

--2.02K

Currency unit

USD

USD

USD

Audit opinions

--

--

--

KeyAI

